Scott discusses the benefits of Gvoke glucagon for low blood sugar emergencies and introduces the Inpen insulin pen that connects to a phone app for enhanced functionality. He highlights the affordability of Inpen through the Inpen Access program, making advanced diabetes therapy more accessible.
